Nivolumab Is a Cost-Effective Second-Line Treatment for Metastatic Renal-Cell Carcinoma
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference19 articles.
1. Bending the cost curve in cancer care;Smith;N Engl J Med,2011
2. Delivering affordable cancer care in high-income countries;Sullivan;Lancet Oncol,2011
3. European perspective on the costs and cost-effectiveness of cancer therapies;Drummond;J Clin Oncol,2007
4. Criteria for deciding cost-effectiveness for expensive anti-cancer agents;Sarin;J Cancer Res Ther,2008
5. Controversies in renal cell carcinoma: treatment choice after progression on vascular endothelial growth factor–targeted therapy;Calvo;Eur J Cancer,2014
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Economic value of toripalimab plus axitinib as first-line treatment for advanced renal cell carcinoma in China: a model-based cost-effectiveness analysis;Expert Review of Pharmacoeconomics & Outcomes Research;2024-03-21
2. Cost-effectiveness of Nivolumab Plus Cabozantinib Versus Cabozantinib as First-Line Treatment of Metastatic Renal Cell Carcinoma;Clinical Genitourinary Cancer;2023-12
3. Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in Switzerland;PharmacoEconomics - Open;2023-02-09
4. Cost-effectiveness of poly-(ADP-ribose) polymerase (PARP)-inhibitors for the maintenance treatment after responding to first- and second-line chemotherapy in advanced ovarian cancer;Journal of Oncology Pharmacy Practice;2022-11-07
5. Brigatinib is a cost-effective treatment in first-line anaplastic lymphoma kinase mutation-positive (ALK + ) advanced non-small cell lung cancer (NSCLC) with brain metastases;Journal of Oncology Pharmacy Practice;2022-01-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3